Copyright: ©Author(s) 2026.
World J Crit Care Med. Jun 9, 2026; 15(2): 118885
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118885
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118885
Table 1 Inclusion and exclusion criteria
| Inclusion | Exclusion |
| Published in English | All languages other than English |
| Data collected on or after March 1, 2023 | Data collected before March 1, 2023 |
| All or part of the analyses targeted FL HCWs caring for patients with COVID-19: Physicians, nurses, advanced practice providers | Reports limited to the context of another pandemic (e.g., Middle East Respiratory Syndrome, influenza) or event (e.g., earthquake or another natural event) not related to the COVID-19 pandemic |
| Reporting quantitative data (e.g., prevalence rates) on psychological problems experienced by FL HCWs after the COVID-19 pandemic | Reports limited to other professionals not working in the health system (i.e., police officers, firefighters, teachers) or healthcare students |
| Reporting quantitative data (e.g., prevalence rates) on psychological problems (i.e., depressive symptoms, anxiety symptoms, insomnia, posttraumatic stress disorder symptoms) and other psychological data, including burnout symptoms, sleep problems, psychological stress and distress) | Reports limited to HCWs who did not perform hospital-based work as a member of the primary healthcare team on hospitalized COVID-19 patients (i.e., dentists, orthopedic surgeons) |
| Reports limited to types of qualitative data other than prevalence rates or results of interventional studies | |
| Reports limited to data on emotions (e.g., fear) or behaviors (e.g., physical activity, smoking) | |
| Reports limited to surges of COVID-19 infection occurring locally at time of study (i.e., several provinces in China had surges in early 2023; studies reporting data collection during these surges were excluded) |
Table 2 Study characteristics, n (%)/mean ± SD
| Ref. | Country | Survey year | Occupation | Comparison | Number of participants | Age (mean ± SD or most common age group) | Men | Depression screen | Anxiety screen | PTSD screen | Sleep screen | Distress screen |
| Azoulay et al[10] | Europe | 2024 | ICU HCWs | None | 850 | 39 ± 7 | 276 (32) | Yes | Yes | No | No | Yes |
| Cheng et al[11] | Taiwan | 2023 | Nurse practitioners | None | 98 | 35-44 | 3 (3.1) | Yes | Yes | No | No | Yes |
| Yang et al[12] | China | 2023 | Nurses | None | 2,065 | 26-35 | 370 (17.9) | Yes | Yes | No | Yes | No |
| Qian et al[13] | China | 2023 | HCWs | FL vs NFL | 1419 | 26-35 | 343 (24.2) | No | No | No | No | Yes |
| Mohr et al[14] | United States | 2018-2023 | HCWs | Year; FL vs NFL | 293164 | 46.3 ± 12.1 | 83258 (28.4) | No | No | No | No | Yes |
| Liu et al[15] | China | 2023 | HCWs | None | 2070 | 25-34 | 469 (22.7) | Yes | Yes | Yes | Yes | No |
| Wen et al[16] | China | 2022, 2023 | Nurses, physicians | Year; ICU | 2292 | 31-40 | 389 (17.0) | No | No | Yes | No | No |
| Narita et al[17] | Japan | 2023 | HCWs | FL vs NFL | 660 | 42.7 ± 10.9 | 214 (32.4) | No | No | Yes | No | No |
| Liu et al[18] | China | 2023 | Nurses | Year | 784 | NR | 366 (49.6) | Yes | Yes | No | Yes | No |
| Giménez-Díez et al[19] | Spain | 2023 | Nurses | Year; FL vs NFL | 1045 | 42.7 ± 10.9 | 128 (12.2) | Yes | Yes | Yes | Yes | No |
| Xu et al[20] | China | 2023 | Nurses, physicians | None | 2094 | < 35 | 517 (24.7) | Yes | Yes | No | No | Yes |
| Xie et al[21] | China | 2023 | Nurses | FL vs NFL | 253 | 18-45 | 22 (8.7) | Yes | Yes | No | Yes | No |
| Wang et al, 2023[22] | China | 2023 | Nurses | None | 2210 | 26-35 | 436 (19.7) | Yes | Yes | No | No | No |
| Zhang et al[23] | China | 2023 | Nurses | FL vs NFL | 2513 | 25-44 | 98 (3.9) | No | No | Yes | No | Yes |
| Wang et al, 2024[24] | China | 2023 | Nurses | None | 2210 | 26-35 | 436 (19.7) | No | No | No | No | Yes |
| Ding et al[25] | China | 2023 | HCWs | FL vs NFL | 1412 | 18-34 | 609 (43.1) | Yes | Yes | No | Yes | No |
| Yang et al[26] | China | 2022, 2023 | Nurses | Year | 816 | NR | 381 (49.9) | Yes | Yes | No | Yes | No |
| Çerçizaj et al[27] | Albania | 2024 | Nurses | FL vs NFL | 288 | 38.6 ± 10.4 | 52 (17.9) | Yes | Yes | No | No | Yes |
| Hoseini-Marvast et al[28] | Iran | 2023 | Nurses | FL vs NFL | 890 | 34.89 ± 7.84 | 107 (12.0) | Yes | Yes | No | No | No |
Table 3 Depression data, n (%)/mean ± SD
| Ref. | Depression screening tool | Positive depression screen definition | Depression prevalence | Depression survey score | Results of comparison |
| Azoulay et al[10] | HADS | 7 of 21 on the depression subscale | 219 (26) | Mean NR; median 4 (IQR: 2-7) | NCG |
| Cheng et al[11] | DASS-21 | > 9 | NR | 8.2 ± 6.9 | NCG |
| Yang et al[12] | SDS | ≥ 40 | NR | 53.6 ± 13.1 | NCG |
| Hoseini-Marvast et al[28] | Beck-2 | Minimal 0-7, mild 8-15, moderate 16-25, severe 26-63 | 845 (50) | 20.8 ± 13.7 | Not significant for comparison between FL vs NFL (data NR) |
| Çerçizaj et al[27] | DASS-21 | Mild 10-13, moderate 14-20, severe 21-27, extremely severe ≥ 28 | Mild 16 (5.6); moderate 11 (3.8); severe/extremely severe 9 (3.1) | NR | OR 2.67 (95%CI: 1.2-6.1) for FL vs NFL |
| Liu et al[15] | PHQ-9 | ≥ 5 | 865 (41.8) (95%CI: 39.7-43.9) | NR | NCG |
| Yang et al[26] | SDS | ≥ 40 | NR | 55.4 ± 12.8 | Mean 62.46 ± 4.69 in 2022 vs 55.4 ± 12.8 in 2023, P < 0.001 |
| Ding et al[25] | PHQ-9 | ≥ 10 | 231 (16.4) | NR | OR 1.66 (95%CI: 1.47-1.9) P < 0.001 for FL vs NFL |
| Liu et al[18] | SDS | ≥ 73 for severe depression | 36 (4.9) | 55.6 ± 12.6 | Prevalence 36 (4.9) in 2023 vs 13 (1.7) in 2022, P < 0.001 |
| Giménez-Díez et al[19] | PHQ-9 | Pooled symptom profile | 191 (73.9) | 8.9 ± 5.9 | OR = 1.38 (95%CI: 1.00-1.90), P = 0.048 FL vs NFL |
| Xu et al[20] | CES-D | Pooled symptom profile | 1300 (62.1) low, 605 (28.9) moderate and 189 (9) high | NR | NCG |
| Xie et al[21] | SDS | ≥ 50 | 137 (64.9) | NR | OR = 1.44 (95%CI: 0.39-1.25), P = 0.017 FL vs NFL |
| Wang et al[22] | SDS | ≥ 50 | NR | 54.3 ± 9.4 | NCG |
Table 4 Anxiety data, n (%)/mean ± SD
| Ref. | Anxiety screening tool | Positive anxiety screen cutoff | Estimated anxiety prevalence | Anxiety survey score | Results of comparison |
| Azoulay et al[10] | HADS | ≥ 7 | 492 (58) | median score 7 (IQR 5-10) | NCG |
| Cheng et al[11] | DASS-21 | > 7 | NR | 6.92 ± 6.32 | NCG |
| Yang et al[12] | SAS | ≥ 50 | NR | 49.62 ± 11.9 | NCG |
| Liu et al[12] | GAD-7 | ≥ 5 | 638 (30.8) (95%CI: 28.8-32.8) | NR | NCG |
| Liu et al[18] | SAS | NR | NR | 51.5 ± 12.2 | Mean SAS 69.6 ± 5.04 in 2022 vs in 51.5 ± 12.2 in 2023, P < 0.001 |
| Giménez-Díez et al[19] | GAD-7 | Dichotomous MH variable (no/mild vs moderate/severe); GAD-7 cutoff not provided | 839 (80.3) | 9.4 ± 5.7 | OR for FL vs NFL 1.38 (95%CI: 1.00-1.90) |
| Xu et al[20] | GAD-7 | Psychological symptom profile created: Low, moderate, and high level | 1300 (62.1) low, 605 (28.9) moderate, and 189 (9) high | NR | NCG |
| Xie et al[21] | GAD-7 | ≥ 5 | 120 (56.9) | NR | OR = 0.67 (95%CI: 0.36-1.24), P = 0.20 |
| Wang et al[22], 2023 | SAS | ≥ 36 | 1438 (65.1) | NR | NCG |
| Ding et al[25] | GAD-7 | ≥ 10 | 254 (18) | NR | OR for FL vs NFL 2.047 (95%CI: 1.68-2.24), P < 0.001 |
| Yang et al[26] | SAS | ≥ 50 | 61 (8.0) | 51.4 ± 12.2 | 426 (52.3) in 2022 vs 61 (8.0) in 2023, P < 0.001 |
| Çerçizaj et al[27] | DASS-21 | Normal 0-7, mild 8-9, moderate 10-14, severe 15-19, extremely severe 20+ | Mild 9 (3.1), moderate 25 (8.7), severe 3 (1), extremely severe 9 (3.1) | NR | OR for FL vs NFL 4.17 (95%CI: 1.6-10.6), P = 0.003 |
| Hoseini-Marvast et al[28] | Beck anxiety inventory | Low 0-13, mild 14-19, moderate 20-28, severe 29-63 | 579 (65) | 22 ± 13.4 | NS FL vs NFL (data NR) |
Table 5 Sleep disorder data, n (%)
| Ref. | Sleep screening tool | Positive sleep screen definition | Sleep prevalence in FL 2023 | mean ± SD | Results of comparison |
| Yang et al[12] | PSQI | ≥ 8 | 1088 (52.70) | 10.11 ± 4.2 | NCG |
| Liu et al[15] | ISI | ≥ 8 | 782 (34.3) (95%CI: 32.2-36.3) | NR | NCG |
| Liu et al[18] | PSQI | ≥ 8 | NR | 9.4 ± 4.7 | 10.7 ± 2.5 in 2022 and 9.4 ± 4.7 in 2023, P < 0.001 |
| Giménez-Díez et al[19] | ISI | NR | 698 (66.80) | 10.8 ± 6.4 | NR |
| Xie et al[21] | PSQI | ≥ 7 | 201 (79.4) | NR | NR |
| Ding et al[25] | ISI | ≥ 15 | 289 (20.5) | NR | OR for FL vs NFL 1.09 (95%CI: 1.02-1.16), P = 0.01 |
| Yang et al[26] | PSQI | ≥ 8 | NR | 9.3 ± 4.7 | 10.7 ± 2.5 in 2022 vs 9.3 ± 4.7 in 2023, P < 0.001 |
Table 6 Distress and turnover intention table, n (%)/mean ± SD
| Ref. | Distress screening tool | Distress screen definition | Distress prevalence in FL 2023 | mean ± SD | Results of comparison |
| Azoulay et al[10] | VAS and intention to leave yes/no | NR | Intention to leave 484 (57); VAS NR | NR | NCG |
| Cheng et al[11] | DASS-21 and Stress Scale of Caring for Patients with Highly-Infectious Disease | > 14 | NR | DASS-21 stress score 1324 ± 8.14; HSS 48.89 ± 18.5 | NCG |
| Qian et al[13] | IES-R; change in work stress and rest time yes/no | NR | NR | IES-R score 173 ± 12.7 | NS increase in work stress and decrease in rest time reported in FL vs NFL |
| Mohr et al[14] | 2 items from MBI and coronavirus disease 2019 professional stress | Burnout ≥ once per week; coronavirus disease 2019 professional stress positive if answered high or extreme stress | 95278 (32.50) | ICU had highest work stress at the start of the pandemic (48.6%) with the greater decline (12.9%) from 2020-2023 than other work areas | |
| Xu et al[20] | MBI | Psychological symptom profile created: Low, moderate, and high level | 1300 (62.1) low level, 605 (28.9) moderate level, and 189 (9) high level | NR | NCG |
| Zhang et al[23] | Turnover Intention Scale | < 6 very low; 6-12 low; 13-18 high; > 19 very high | High turnover intention 804 (32) and very high 302 (12) | NR | FL 2.09 ± 0.88 vs NFL 1.85 ± 1.85, P < 0.01 |
| Wang et al[24] | MBI-HSS | > 26 in EE, > 9 in D, and < 33 in PA | 1666 (75.38) | NR | NCG |
| Çerçizaj et al[27] | DASS-21 | Normal 0-14, mild 15-18, moderate 19-25, severe 26-33, extremely severe ≥ 34 | Mild 3 (1.0), Moderate 0 (0), severe or extremely severe 0 (0) | NR | NR |
- Citation: Adams TN, Patel HJ, North CS. Long-term psychological outcomes among frontline healthcare workers following the COVID-19 pandemic: A systematic review. World J Crit Care Med 2026; 15(2): 118885
- URL: https://www.wjgnet.com/2220-3141/full/v15/i2/118885.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v15.i2.118885